Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss.

Hamel, Charlotte C; Snijders, Marcus P L M; Coppus, Sjors F P J; Vandenbussche, Frank P H A; Braat, Didi D M; Adang, Eddy M M

Hamel, Charlotte C; Snijders, Marcus P L M; Coppus, Sjors F P J; Vandenbussche, Frank P H A; Braat, Didi D M; Adang, Eddy M M.

Afiliación

Hamel CC; Radboud University Medical Centre, Department of Obstetrics and Gynaecology, Nijmegen, GA, The Netherlands.
Snijders MPLM; Department of Obstetrics and Gynaecology, Canisius-Wilhelmina Hospital, Nijmegen, GS, The Netherlands.
Coppus SFPJ; Department of Obstetrics and Gynaecology, Canisius-Wilhelmina Hospital, Nijmegen, GS, The Netherlands.
Vandenbussche FPHA; Maxima Medical Centre, Department of Obstetrics and Gynaecology, Veldhoven, DB, The Netherlands.
Braat DDM; Radboud University Medical Centre, Department of Obstetrics and Gynaecology, Nijmegen, GA, The Netherlands.
Adang EMM; Department of Obstetrics and Gynaecology, Helios Klinikum Duisburg, Duisburg, Germany.

PLoS One ; 17(2): e0262894, 2022.

Article en En | MEDLINE | ID: mdl-35139105

Asunto(s)

Mifepristona

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mifepristona Tipo de estudio: Clinical_trials / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google